Bio-Rad Laboratories, Inc. Price Today
Bio-Rad Laboratories, Inc.
BIO
Healthcare
$9.22B
💰
Market Cap
0
💸
Price to Earnings
$-21.8
🎉
EPS
+83
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
4 |
Strong Buy |
3 |
Hold |
3 |
Sell |
0 |
Strong Sell |
0 |
BIO Price Forecast Target
326.3 👉 480.0 +47%
BIO EPS Forecast
-21.8 👉 12.2 +-156%
Financials
Profit Margin
-24 %
Revenue Growth
-6.7 %
Dividend
$ 0
Held Percent
15.2% - Insiders
81.7% - Institutions
3.1% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $779.9M
-
💰 Blackrock Inc. $478.5M
-
💰 Veritas Asset Management LLP $353.4M
-
💰 State Street Corporation $285.5M
-
💰 Ubs Asset Management Americas Inc $164.2M
Stock Ideas
Jim Chanos Portfolio
Jim Chanos is a revered figure in the world of portfolio management, known for his expertise in short selling and his pivotal role in uncovering fraud at Enron and WorldCom. Hailing from Milwaukee and a graduate of Yale with an economics degree, Ch…
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Stanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcar…
Jim Simons Portfolio
Jim Simons, the mastermind behind the Medallion Fund, has achieved such extraordinary returns that he has skyrocketed to the ranks of the world's wealthiest individuals. The secret to his success lies in the fund's implementation of high-frequency t…📮FAQ
Some Frequently Asked Questions.
The Bio-Rad Laboratories, Inc. industry is Medical Devices
The Bio-Rad Laboratories, Inc. sector is Healthcare
The Bio-Rad Laboratories, Inc. forecasted predicted Price to Earnings PE ratio is 26.9
The Bio-Rad Laboratories, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of Bio-Rad Laboratories, Inc. is $9.22B
There are total of 19954920 float shares with 81.7% held by Institutions and 15.2% held by insiders
The MBio-Rad Laboratories, Inc. forecasted Earnings per Share EPS is $12.2
The Bio-Rad Laboratories, Inc. Earnings per Share EPS is -21.8
The Bio-Rad Laboratories, Inc. company has $0 gross profits with -24 profit margins
The Bio-Rad Laboratories, Inc. Earnings Growth is -0.563% with -0.578% quarterly earnings growth
The Bio-Rad Laboratories, Inc. Revenue is $2671261952 with -0.067 revenue growth
The price target for Bio-Rad Laboratories, Inc. stock is $480.0 for the high target and $350.0 for the low target
The consensus analyst recommendations for Bio-Rad Laboratories, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Bio-Rad Laboratories, Inc. is Buy, with the following breakdown:
- Buy: 4
- Strong Buy: 3
- Hold: 3
- Sell: 0
- Strong Sell: 0
The Beta of Bio-Rad Laboratories, Inc. is 0.9
The dividend of Bio-Rad Laboratories, Inc. is $0
The dividend yield of Bio-Rad Laboratories, Inc. is 0%
The biggest institutional and mutual fund holders of Bio-Rad Laboratories, Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Veritas Asset Management LLP
- State Street Corporation
The Bio-Rad Laboratories, Inc. ESG Score is 83, with the following breakdown:
- E: 1.21
- S: 9.18
- G: 7.0